Appili Therapeutics Inc Class A (TSE:APLI) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Appili Therapeutics Inc., a biopharmaceutical company, has amended its arrangement agreement for the acquisition of its Class A common shares by Aditxt, Inc., extending key deadlines into September 2024. This revision includes a new deadline for Aditxt to complete necessary financing and for holding a special shareholders’ meeting.
For further insights into TSE:APLI stock, check out TipRanks’ Stock Analysis page.
